Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Heirman

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
European Journal of Immunology|September 18, 2015
The transduction pattern of IL-12-encoding lentiviral vectors shapes the immunological outcomeCleo Goyvaerts, Katrijn Broos, David Escors, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 2014
Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formulaSandra Van Lint, Sofie Wilgenhof, Carlo Heirman, et al.
Cancer Gene Therapy|August 22, 2002
Efficient genetic modification of murine dendritic cells by electroporation with mRNASonja Van Meirvenne, Lieven Straetman, Carlo Heirman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2016
Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced MelanomaSofie Wilgenhof, Jurgen Corthals, Carlo Heirman, et al.
European Journal of Immunology|February 16, 2007
CD83 expression on dendritic cells and T cells: correlation with effective immune responsesCindy Aerts-Toegaert, Carlo Heirman, Sandra Tuyaerts, et al.
Cancer Gene Therapy|August 29, 2003
Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cellsSandra Tuyaerts, Annelies Michiels, Jurgen Corthals, et al.
Cancer Immunology, Immunotherapy : CII|June 21, 2014
Immunomodulatory drugs improve the immune environment for dendritic cell-based immunotherapy in multiple myeloma patients after autologous stem cell transplantationBrenda De Keersmaecker, Karel Fostier, Jurgen Corthals, et al.
Cancer Immunology, Immunotherapy : CII|December 31, 2014
Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastasesSofie Wilgenhof, Jurgen Corthals, An M T Van Nuffel, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Adjuvant-Enhanced mRNA VaccinesLukasz Bialkowski, Kevin Van der Jeught, Dries Renmans, et al.
Journal of Leukocyte Biology|June 24, 2008
Neutrophil-dependent tumor rejection and priming of tumoricidal CD8+ T cell response induced by dendritic cells overexpressing CD95LSofia Buonocore, Najate Ouled Haddou, Fabrice Moore, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
European Journal of Immunology|September 18, 2015
The transduction pattern of IL-12-encoding lentiviral vectors shapes the immunological outcomeCleo Goyvaerts, Katrijn Broos, David Escors, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 2014
Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formulaSandra Van Lint, Sofie Wilgenhof, Carlo Heirman, et al.
Cancer Gene Therapy|August 22, 2002
Efficient genetic modification of murine dendritic cells by electroporation with mRNASonja Van Meirvenne, Lieven Straetman, Carlo Heirman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2016
Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced MelanomaSofie Wilgenhof, Jurgen Corthals, Carlo Heirman, et al.
European Journal of Immunology|February 16, 2007
CD83 expression on dendritic cells and T cells: correlation with effective immune responsesCindy Aerts-Toegaert, Carlo Heirman, Sandra Tuyaerts, et al.
Cancer Gene Therapy|August 29, 2003
Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cellsSandra Tuyaerts, Annelies Michiels, Jurgen Corthals, et al.
Cancer Immunology, Immunotherapy : CII|June 21, 2014
Immunomodulatory drugs improve the immune environment for dendritic cell-based immunotherapy in multiple myeloma patients after autologous stem cell transplantationBrenda De Keersmaecker, Karel Fostier, Jurgen Corthals, et al.
Cancer Immunology, Immunotherapy : CII|December 31, 2014
Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastasesSofie Wilgenhof, Jurgen Corthals, An M T Van Nuffel, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Adjuvant-Enhanced mRNA VaccinesLukasz Bialkowski, Kevin Van der Jeught, Dries Renmans, et al.
Journal of Leukocyte Biology|June 24, 2008
Neutrophil-dependent tumor rejection and priming of tumoricidal CD8+ T cell response induced by dendritic cells overexpressing CD95LSofia Buonocore, Najate Ouled Haddou, Fabrice Moore, et al.
Pageof 8